Inflammation 2003-Sixth World Congress. Nitric oxide and IBD. 2-6 August 2003, Vancouver, Canada.
Evans
Ruth
R
Thomson Current Drugs Middlesex House 34-42 Cleveland Street London, UK. ruth.evans@current-drugs.com
D000818:Animals; D001955:British Columbia; D016861:Cyclooxygenase Inhibitors / Q000737:chemistry / Q000627:therapeutic use; D015507:Drugs, Investigational / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000201:enzymology; D038622:Internationality; D043183:Irritable Bowel Syndrome / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology*; D009288:Naproxen / Q000737:chemistry / Q000627:therapeutic use; D009569:Nitric Oxide / Q000737:chemistry / Q000627:therapeutic use*
D016861:Cyclooxygenase Inhibitors; D015507:Drugs, Investigational; D009569:Nitric Oxide; D009288:Naproxen